Mirena 52 MG systems

Ended Awarded Last action

Contract number
SPE2DR26FHVM3
Awardee
Awarding agency
Obligated
$3,285

Award facts

Contract value 100% obligated
$3,284.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $3,284.88 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Mirena 52 mg systems under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with an ultimate completion date of March 27, 2026.

Quick answers

Who was awarded contract SPE2DR26FHVM3?

SPE2DR26FHVM3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 6, 2026.

How much is contract SPE2DR26FHVM3 worth?

The government has obligated $3,285 on SPE2DR26FHVM3.

Is contract SPE2DR26FHVM3 an order under another contract?

Yes. SPE2DR26FHVM3 is a delivery order under SPE2DR25D9768, an indefinite delivery contract.

Was contract SPE2DR26FHVM3 competed?

The extent of competition for SPE2DR26FHVM3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award